Inverse Association Between Serum Uric Acid Levels and Alzheimer’s Disease Risk

Molecular Neurobiology

Volumn 53, Issue 4, 2016, Pages 2594-2599

  Du, Na ^a   Xu, Donghua ^b   Hou, Xu ^a   Song, Xuejia ^a   Liu, Cancan ^a   Chen, Ying ^a   Wang, Yangang ^a   Li, Xin ^c  

^a QINGDAO UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c Functional Laboratory of Weifang Medical University   (China)

Author keywords

Alzheimer s disease; Meta analysis; Uric acid

Indexed keywords

URIC ACID;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; HUMAN; LOW RISK POPULATION; META ANALYSIS; NEUROPROTECTION; RISK ASSESSMENT; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; BLOOD; PUBLISHING; RISK FACTOR;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; HUMANS; PUBLICATION BIAS; RISK FACTORS; URIC ACID;

EID: 84931445606     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9271-6     Document Type: Article

References (48)

1. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 10(9):819–828
2. Johansson JU, Woodling NS, Wang Q, Panchal M, Liang X, Trueba-Saiz A, Brown HD, Mhatre SD et al (2014) Prostaglandin signaling suppresses beneficial microglial function in Alzheimer’s disease models. J Clin Invest
3. Benz N, Hatz F, Bousleiman H, Ehrensperger MM, Gschwandtner U, Hardmeier M, Ruegg S, Schindler C et al (2014) Slowing of EEG background activity in Parkinson’s and Alzheimer’s disease with early cognitive dysfunction. Front Aging Neurosci 6314
4. McCord MC, Aizenman E (2014) The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease. Front Aging Neurosci 677
5. Patrone C, Eriksson O, Lindholm D (2014) Diabetes drugs and neurological disorders: new views and therapeutic possibilities. Lancet Diabetes Endocrinol 2(3):256–262
6. Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA (2014) Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2(3):246–255
7. Geijselaers SL, Sep SJ, Stehouwer CD, Biessels GJ (2014) Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol
8. Tuligenga RH, Dugravot A, Tabak AG, Elbaz A, Brunner EJ, Kivimaki M, Singh-Manoux A (2014) Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol 2(3):228–235
9. Borza LR (2014) A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases. Rev Med Chir Soc Med Nat Iasi 118(1):19–27
10. Ghaemi-Oskouie F, Shi Y (2011) The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep 13(2):160–166
11. Alvarez-Lario B, Macarron-Vicente J (2011) Is there anything good in uric acid? QJM 104(12):1015–1024
12. Shih CY, Chen CY, Wen CJ, Liu HM, Kuo HK (2012) Relationship between serum uric acid and cerebral white matter lesions in the elderly. Nutr Metab Cardiovasc Dis 22(2):154–159
13. Vannorsdall TD, Jinnah HA, Gordon B, Kraut M, Schretlen DJ (2008) Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke 39(12):3418–3420
14. Maesaka JK, Wolf-Klein G, Piccione JM, Ma CM (1993) Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer’s disease. J Am Geriatr Soc 41(5):501–506
15. Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT (1999) Plasma chain-breaking antioxidants in Alzheimer’s disease, vascular dementia and Parkinson’s disease. QJM 92(1):39–45
16. Carantoni M, Zuliani G, Munari MR, D’Elia K, Palmieri E, Fellin R (2000) Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels. Dement Geriatr Cogn Disord 11(3):176–180
17. Polidori MC, Mecocci P (2002) Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis 4(6):517–522
18. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R et al (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 24(7):915–919
19. Polidori MC, Mattioli P, Aldred S, Cecchetti R, Stahl W, Griffiths H, Senin U, Sies H et al (2004) Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 18(3–4):265–270
20. Pulido R, Jimenez-Escrig A, Orensanz L, Saura-Calixto F (2005) Study of plasma antioxidant status in Alzheimer’s disease. Eur J Neurol 12(7):531–535
21. Kim TS, Pae CU, Yoon SJ, Jang WY, Lee NJ, Kim JJ, Lee SJ, Lee C et al (2006) Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 21(4):344–348
22. Iuliano L, Monticolo R, Straface G, Spoletini I, Gianni W, Caltagirone C, Bossu P, Spalletta G (2010) Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer’s disease. J Alzheimers Dis 21(4):1383–1392
23. Can M, Varlibas F, Guven B, Akhan O, Yuksel GA (2013) Ischemia modified albumin and plasma oxidative stress markers in Alzheimer’s disease. Eur Neurol 69(6):377–380
24. Al-Khateeb E, Althaher A, Al-Khateeb M, Al-Musawi H, Azzouqah O, Al-Shweiki S, Shafagoj Y (2014) Relation between uric acid and Alzheimer’s disease in elderly Jordanians. J Alzheimers Dis
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
27. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
28. Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, Morillas JM (2006) Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chem 13(9):1075–1083
29. Cankurtaran M, Yesil Y, Kuyumcu ME, Ozturk ZA, Yavuz BB, Halil M, Ulger Z, Cankurtaran ES et al (2013) Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer’s disease. J Alzheimers Dis 33(4):1051–1058
30. Cervellati C, Cremonini E, Bosi C, Magon S, Zurlo A, Bergamini CM, Zuliani G (2013) Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer’s disease. Curr Alzheimer Res 10(4):365–372
31. Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, Passaro A, Bergamini CM et al (2014) Oxidative balance, homocysteine, and uric acid levels in older patients with late onset Alzheimer’s disease or vascular dementia. J Neurol Sci 337(1–2):156–161
32. Nazef K, Khelil M, Chelouti H, Kacimi G, Bendini M, Tazir M, Belarbi S, El Hadi CM et al (2014) Hyperhomocysteinemia is a risk factor for Alzheimer’s disease in an Algerian population. Arch Med Res 45(3):247–250
33. Euser SM, Hofman A, Westendorp RG, Breteler MM (2009) Serum uric acid and cognitive function and dementia. Brain 132(Pt 2):377–382
34. Irizarry MC, Raman R, Schwarzschild MA, Becerra LM, Thomas RG, Peterson RC, Ascherio A, Aisen PS (2009) Plasma urate and progression of mild cognitive impairment. Neurodegener Dis 6(1–2):23–28
35. Wu Y, Zhang D, Pang Z, Jiang W, Wang S, Tan Q (2013) Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50–74 years. Geriatr Gerontol Int 13(3):672–677
36. Shang X, Zhang F, Meng L, Zhang W, Lin M, Xue Y (2009) Relationship between the level of serum uric acid and Alzheimer’s disease [article in Chinese]. J China Med Univ 38(5):333–334
37. Huang D, Lu Z, Tan S, Yang H, Yang Y (2012) Study on the correlation of uric acid levels with Alzheimer’s disease [article in Chinese]. Guangxi Med Univ 34(11):1483–1485
38. Zhou Y, Tan H, Wang A (2012) Study on the relationship between uric acid and various cognitive functions in Alzheimer’s disease [article in Chinese]. J Chin Physician 14(7):904–906
39. Sun X, Pan F, Huang G (2013) Relationship between the cognitive function and the level of serum uric acid in Alzheimer’s disease [article in Chinese]. Geriatr Health Care 19(6):380–382
40. Yang J (2014) Uric acid test for Alzheimer’s disease and vascular dementia patients [article in Chinese]. Mod Diagn Treat 25(1):161–162
41. Fitzsimons CP, van Bodegraven E, Schouten M, Lardenoije R, Kompotis K, Kenis G, van den Hurk M, Boks MP et al (2014) Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease. Mol Neurodegener 925
42. Marr RA, Hafez DM (2014) Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci 6187
43. Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML et al (2014) Recommendations of the Alzheimer’s disease-related dementias conference. Neurology 83(9):851–860
44. Poirier J, Miron J, Picard C, Gormley P, Theroux L, Breitner J, Dea D (2014) Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer’s disease. Neurobiol Aging 35(Suppl 2):S3–S10
45. Cukierman-Yaffe T, Bosch J, Diaz R, Dyal L, Hancu N, Hildebrandt P, Lanas F, Lewis BS et al (2014) Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial. Lancet Diabetes Endocrinol 2(7):562–572
46. Martinez-Finley EJ, Avila DS, Chakraborty S, Aschner M (2011) Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases. Metallomics 3(3):271–279
47. Sultana R, Butterfield DA (2009) Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 41(5):441–446
48. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA (2000) Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376(2):333–337